# Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

> **NCT01270282** · PHASE2 · COMPLETED · sponsor: **Auris Medical, Inc.** · enrollment: 82 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** AM-101 0.81 mg/mL
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01270282
- **Lead sponsor:** Auris Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2015-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01270282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01270282, "Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01270282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*